Ruymara Candal Nogueira
Ruymara Candal Nogueira has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Andressa Gonçalves Vicente
Centro Universitário Fundação Assis Gurgacz
1 shared publication - Anita dos Santos Cardoso
Universidade do Extremo Sul Catarinense
1 shared publication - Brunella Flores Pupo
Universidade do Extremo Sul Catarinense, Brasil; Aura Neurologia, Brasil
1 shared publication - Carlos Vinícius Teixeira Palhares
Faculdade Ciências Médicas de Minas Gerais image/svg+xml
1 shared publication - Emilly da Silva Dela Costa1 shared publication
- Fernando Topanotti Tarabay
Aura Neurologia, Brasil
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 25
Bilateral carotid dissection due to Eagle syndrome: case report
Eagle Syndrome (ES), characterized by elongation of the styloid process (ESP), is a rare condition with diverse symptoms. Among its complications, carotid dissection is a significant outcome requiring accurate diagnosis and intervention. This study describes a case of bilateral carotid dissection associated with ES, emphasizing diagnostic challenges, management, and therapeutic approaches. Conducted under Research Ethics Committee protocol 68193123.5.0000.0119 and approval number 6.028.970, it reports on a 38-year-old woman with a 5-day history of left-sided headache, otalgia, syncope, right-hand limitation, and visual blurring. MRI revealed left carotid bulb occlusion and recent ischemic events, while angio-CT confirmed bilateral carotid dissections. After clinical management failed, an intraoral surgical approach was chosen, resulting in full neurological recovery. CT confirmed ESP, and genetic testing was negative. This case highlights the need to consider ES in atypical cervicofacial symptoms, given its underdiagnosed incidence (~4% for ESP; ~0.16% for ES), reinforcing the importance of better clinical guidelines.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 25
Open AccessBilateral carotid dissection due to Eagle syndrome: case report
Eagle Syndrome (ES), characterized by elongation of the styloid process (ESP), is a rare condition with diverse symptoms. Among its complications, carotid dissection is a significant outcome requiring accurate diagnosis and intervention. This study describes a case of bilateral carotid dissection associated with ES, emphasizing diagnostic challenges, management, and therapeutic approaches. Conducted under Research Ethics Committee protocol 68193123.5.0000.0119 and approval number 6.028.970, it reports on a 38-year-old woman with a 5-day history of left-sided headache, otalgia, syncope, right-hand limitation, and visual blurring. MRI revealed left carotid bulb occlusion and recent ischemic events, while angio-CT confirmed bilateral carotid dissections. After clinical management failed, an intraoral surgical approach was chosen, resulting in full neurological recovery. CT confirmed ESP, and genetic testing was negative. This case highlights the need to consider ES in atypical cervicofacial symptoms, given its underdiagnosed incidence (~4% for ESP; ~0.16% for ES), reinforcing the importance of better clinical guidelines.
- Open Access
- 1 February 2024
- Published by Research, Society and Development in Research, Society and Development
- Vol. 13 (2)
Análise terapêutica do canabidiol para o tratamento de Alzheimer
Objective: To analyze therapeutic evidence regarding the potential antioxidant, anti-inflammatory and neuroprotective effects of cannabidiol (CBD) and its effectiveness for the treatment of Alzheimer's Disease (AD). Methodology: Data collection, in the Virtual Health Library, targeting the primary databases Medical Literature Analysis and Retrieval System Online (Medline) and Latin American and Caribbean Literature in Health Sciences (Lilacs) to answer the research question: is the therapeutic use of cannabidiol effective in improving the treatment of patients with Alzheimer's Disease? Results: 14 articles were selected, after analyzing the inclusion and exclusion criteria, all after 2017, with the largest number concentrating on systematic literature review or meta-analysis. Conclusion: Cannabidiol has clear potential to reduce the symptoms of AD given its action on the Central Nervous System. Therefore, its therapeutic use in the treatment of AD emerges as a promising field of investigation, highlighting its relevance as a safe and effective treatment option. Therefore, an in-depth understanding of the antioxidant, anti-inflammatory and neuroprotective properties of CBD is necessary, not only for a better clinical definition of AD, but also for a series of neurological diseases that still have undefined treatments. The potential of CBD, therefore, represents a valuable alternative in the context of neurology, offering significant perspectives for the treatment of neurodegenerative conditions.
- 1 February 2024
- Published by Research, Society and Development in Research, Society and Development
- Vol. 13 (2)
Open AccessAnálise terapêutica do canabidiol para o tratamento de Alzheimer
Objective: To analyze therapeutic evidence regarding the potential antioxidant, anti-inflammatory and neuroprotective effects of cannabidiol (CBD) and its effectiveness for the treatment of Alzheimer's Disease (AD). Methodology: Data collection, in the Virtual Health Library, targeting the primary databases Medical Literature Analysis and Retrieval System Online (Medline) and Latin American and Caribbean Literature in Health Sciences (Lilacs) to answer the research question: is the therapeutic use of cannabidiol effective in improving the treatment of patients with Alzheimer's Disease? Results: 14 articles were selected, after analyzing the inclusion and exclusion criteria, all after 2017, with the largest number concentrating on systematic literature review or meta-analysis. Conclusion: Cannabidiol has clear potential to reduce the symptoms of AD given its action on the Central Nervous System. Therefore, its therapeutic use in the treatment of AD emerges as a promising field of investigation, highlighting its relevance as a safe and effective treatment option. Therefore, an in-depth understanding of the antioxidant, anti-inflammatory and neuroprotective properties of CBD is necessary, not only for a better clinical definition of AD, but also for a series of neurological diseases that still have undefined treatments. The potential of CBD, therefore, represents a valuable alternative in the context of neurology, offering significant perspectives for the treatment of neurodegenerative conditions.
- Open Access
- 10 January 2024
- Published by Brazilian Journals in Cuadernos de Educación y Desarrollo
- Vol. 16 (2 Edição E)
Aleitamento materno: sua relação com a depressão pós parto e dificuldades
A gestação é considerada um período de constantes mudanças e transformações fisiológicas, emocionais, sociais e psicológicas. O aleitamento concretiza o vínculo de mãe e filho no puerpério, trazendo benefícios nutritivos e psicológicos a ambos. De acordo com estudos mundiais apenas 16% praticam aleitamento materno exclusivo (AME). A qualidade da amamentação é pior em países subdesenvolvidos, de forma que apenas 2 de cada 10 crianças recebem AME. Fatores inerentes para mãe e/ou o bebê podem estar relacionados com a interrupção precoce do aleitamento materno, um desses fatores é a depressão pós-parto (DPP).
- 10 January 2024
- Published by Brazilian Journals in Cuadernos de Educación y Desarrollo
- Vol. 16 (2 Edição E)
Open AccessAleitamento materno: sua relação com a depressão pós parto e dificuldades
A gestação é considerada um período de constantes mudanças e transformações fisiológicas, emocionais, sociais e psicológicas. O aleitamento concretiza o vínculo de mãe e filho no puerpério, trazendo benefícios nutritivos e psicológicos a ambos. De acordo com estudos mundiais apenas 16% praticam aleitamento materno exclusivo (AME). A qualidade da amamentação é pior em países subdesenvolvidos, de forma que apenas 2 de cada 10 crianças recebem AME. Fatores inerentes para mãe e/ou o bebê podem estar relacionados com a interrupção precoce do aleitamento materno, um desses fatores é a depressão pós-parto (DPP).